Compare NRP & LMRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRP | LMRI |
|---|---|---|
| Founded | 2002 | 2018 |
| Country | United States | United States |
| Employees | N/A | 4335 |
| Industry | Coal Mining | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2002 | N/A |
| Metric | NRP | LMRI |
|---|---|---|
| Price | $97.60 | $11.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $20.75 |
| AVG Volume (30 Days) | 36.0K | ★ 571.0K |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $216,119,000.00 | N/A |
| Revenue This Year | N/A | $6.35 |
| Revenue Next Year | N/A | $5.61 |
| P/E Ratio | $11.28 | ★ N/A |
| Revenue Growth | ★ 54.66 | N/A |
| 52 Week Low | $95.51 | $6.45 |
| 52 Week High | $128.60 | $19.45 |
| Indicator | NRP | LMRI |
|---|---|---|
| Relative Strength Index (RSI) | 41.89 | 54.66 |
| Support Level | $97.39 | $10.21 |
| Resistance Level | $101.78 | $12.93 |
| Average True Range (ATR) | 2.26 | 0.74 |
| MACD | 0.20 | -0.18 |
| Stochastic Oscillator | 33.96 | 30.24 |
Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. The majority of the revenue is generated from the Mineral Rights segment. Geographically, the company's business activity of the group functions through the United States.
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.